Ophthalmic Products List

Ophthalmic Product List – An ophthalmic Product could be a solution, suspension, ointment, or emulsion. A typical eye care product is sterile, nearly isotonic has some buffering capacity, contains anti-microbial agents (unless the act itself is bacteriostatic), and is packaged into a suitable tamper-evident, multi-dose dispensing system. However, there is a growing trend to invest in multi-dose, preservative-free formulations. Ophthalmic drug forms have been one of the most important and widely developed areas of pharmaceutical technology for dozens of years.

I am here with my next blog which is about Ophthalmic Products List. In this Blog I have covered the Recent market trends and size, segmentation, demands, the main player in this field, product list details, etc. about ophthalmic Products and drugs. The main reason for the continuingly strong interest of scientists in the preparation of ophthalmic drug forms is the problem of low bioavailability of medicinal substances after their application to the eyeball.

The manufacturing processes should meet the requirements of Good Manufacturing Practices, especially with regard to cross-contamination. It is essential that ophthalmic preparations are sterile. Packaging must be adequate to protect ophthalmic preparations from light, moisture, microbial contamination, and damage due to handling and transportation. Ophthalmic preparations should maintain their integrity throughout their shelf-life when stored at the temperature indicated on the label.

Market Overview of Ophthalmic Products in India

India is the fastest-growing economy in the world and has a tremendous unmet need for ophthalmic Pharmaceutical care. In India, the pharmaceutical ophthalmic market has grown from around 1400 crores INR in 2014 to 2200 crores INR in 2018. Currently, this market is growing at a rate of 6.4% (2019). At the end of 2030, it will grow to INR 10,000 crore. Glaucoma and tear substitutes (for dry eye) lead the pharmaceutical market in India.

The introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders. The other key factors that boost the ophthalmic drug market size include

• High prevalence of glaucoma worldwide and rise in the transition towards the development of combination therapies for the treatment of glaucoma.
• In addition, the dynamics in the demographics across the globe contribute to the market growth.

Moreover, an increase in investment by market players in emerging economies offers lucrative opportunities for market growth in the near future.

Ophthalmic Products Market Key Segments

Owing to the rising cases of eye diseases, the demand for an effective treatment option has also been escalating. In recent years, various new and existing marketers have come up with effective drugs.

• The ophthalmic drugs industry is segmented based on indications into dry eye, glaucoma, infection/inflammation/allergy, retinal disorders, and others. Retinal disorders indication has registered a significant growth rate, registering a CAGR of 5.8% from 2017 to 2023. The dry age-related macular degeneration segment accounted for the highest share among all retinal disorders in 2016 and is expected to continue this trend throughout the forecast period.
• The ophthalmic drugs industry analysis is segmented based on dosage form into liquid, solid, semisolid, multicompartment drug delivery systems, and other ophthalmic drug forms. The liquid ophthalmic drug form segment accounted for the highest revenue in 2016 and is projected to maintain the trend throughout the forecast period.
• Based on geography, the market is divided into North America, Europe, Asia-Pacific, and LAMEA. North America dominates the global market, accounting for 36% of the total market share in 2016, and is anticipated to lead throughout the forecast period.
• According to the dosage form, the market is segmented into gels, capsules and tablets, eye solutions, eye drops, and ointments. Eye drops led the market in 2018 and are likely to witness the fastest growth as they are more cost-effective than other dosage forms.
• Based on product type, the market is segmented into OTC and prescription drugs. Prescription drugs were the largest segment in 2018 as these are more effective than OTC and are used in medical treatments, such as cataracts and post-surgery inflammations.

Key Vendors in Ophthalmic Products Market

Key players in the Ophthalmic Drugs market employ new ideas and concepts, improve production processes, and improve the existing set of products. The key players, therefore, have taken product development as their key development strategy to be consistent with end users ‘ demands.

Key players operating in the Ophthalmic Products market are

• Santen Pharmaceutical Co., Ltd.
• Bausch & Lomb Inc. (Valeant Pharmaceuticals International, Inc.)
• Shire Plc
• Alcon (Novartis)
• Genentech
• Inc. Allergan
• Sun Pharmaceutical Industries Limited
• Actavis Generics (Teva Pharmaceutical Industries Ltd.)
• Regeneron Pharmaceuticals
• Pfizer Inc.

Ophthalmic Products List Types with drugs and Generic names

Conclusion:

The above-listed blog has the proper details about the Ophthalmic Product List. I hope the information granted in my article on pharmaadda will help you in either way. You can follow the list and opt the ophthalmic products accordingly for your PCD or manufacturing business.

Aditi

Hi, I am Aditi. I have a Degree in M.SC. Biotech. I love to write content related to the Pharmaceutical industry. I have been writing content related to the pharmaceutical industry for the past 5 years. I also have a work experience of more than 3 years as a research scientist. Linkedin Profile